Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The typical patient profile for whom MIC B12 represents good value: confirmed or suspected B12 deficiency, seeking energy improvement and modest weight-loss support, not ready for or not qualifying for GLP-1 therapy, willing to self-inject weekly
Out of the three brand-name versions of semaglutide, Wegovy is the only one whose prescribing information (PI) lists hair loss as a potential adverse reaction
The dataset spans a time period from September 1, 2002, to December 1, 2022
Free shipping on $40+
US$ 21.35
US$ 22.05
US$ 29.79
US$ 25.04
US$ 20.38
